FIELD: medicine.
SUBSTANCE: invention concerns medicine, in particular, ophthalmology, and concerns inhibitions of neovascularisation of retina. For this purpose it is offered to use derivative of hydroxamic acid, chosen of suberoylanilide hydroxamic acid (SAHA), Trichostatin A, and/or Scriptaid.
EFFECT: chosen derivatives provide effective inhibition of the VEGF-induced proliferation and life expectancy of endothelial cells of a retina.
5 ex, 1 tbl
Authors
Dates
2009-04-20—Published
2003-10-30—Filed